A small set of structurally different monocarbonyl curcuminoids was prepared and screened for cytotoxic activity. In particular, bis-3-methoxy-4-hydroxy-and bis-4-methoxyphenyl-substituted monocarbonyls were synthesized and transformed into the corresponding three-dimensional N-acetylpyrazoline derivatives. In addition, a non-symmetrical indole-based monocarbonyl curcumin was prepared as well. Preliminary cytotoxic evaluation revealed significant effects for 4-hydroxy (pyrazoline) monocarbonyl curcuminoids, whereas the non-phenolic variants displayed rather poor activity.
Introduction
Curcumin, a natural compound extracted from the rhizomes of Curcuma longa, is a popular food additive and a traditional medicine in South Asia. Curcumin has been explored by many researchers, focusing on a broad diversity of biological activities such as antioxidant, anti-inflammatory, antimicrobial, anticancer, and antimalarial properties. Especially in the field of oncology, curcumin has attracted particular attention because of promising prospects for future applications [1] .
During the last decade, synthetic modifications of the curcumin molecular framework, mainly aimed at improving its bioactivities, have been studied intensively [2] . However, the potential beneficial effects of this natural product on various diseases, especially on cancer, are overshadowed by its unstable chemical structure. Due to the β-diketone moiety, curcumin is rapidly metabolized by aldo-keto reductase enzymes in the liver [3] . Evidence suggests that the β-diketone moiety and its active methylene group in the structure of curcumin contribute significantly to curcumin instability under physiological conditions and induce rapid degradation and metabolization [4, 5] . To identify the key structural motifs responsible for bioactivity and to create opportunity for designing new analogs with a better activity/ stability profile, monocarbonyl curcumins have been proposed in the literature as simplified curcumin derivatives [6] [7] [8] [9] [10] . The results of previous research on monocarbonyl curcuminoids indicate that bioactive representatives are chemically more stable than curcumin in vitro and provide interesting anti-inflammatory and/or antiproliferative effects [11] . Moreover, pyrazole-containing analogs and their derivatives are known to act as antitubercular [12] and antitumor agents [13] , rendering the incorporation of this azaheterocyclic scaffold into the curcumin framework a valuable strategy. Keeping these observations in mind, and elaborating on our recent contributions to the field of curcumin research [14] [15] [16] [17] [18] , we aimed at synthesizing a few (non-)symmetrical and cyclized monocarbonyl curcuminoids to preliminarily assess their potential as cytotoxic agents.
Results and discussion
The synthesis and structures of the target compounds are shown in Scheme 1. Briefly, saturated NaOH in methanol was added dropwise to a mixture of either 3-methoxy-4-hydroxybenzaldehyde (1a, R 1 =OMe, R 2 =OH, vanillin) or 4-methoxybenzaldehyde (1b, R 1 =H, R 2 =OMe) and acetone at room temperature to furnish the desired (1E,4E)-1,5bisarylpenta-1,4-dien-3-ones 2a, 2b [19, 20] . Moreover, in the pursuit of a non-symmetrical analog, intermediate (E)-4-(4-hydroxy-3-methoxyphenyl)but-3-en-2-one (4), obtained by monocondensation of vanillin with acetone [21] , was reacted with indole-3-carboxaldehyde in basic conditions through aldol condensation to deliver (1E,4E)-1-(4-hydroxy-3-methoxyphenyl)-5-(1H-indol-3-yl)penta-1,4-dien-3-one (5) . The choice for indole-3-carboxaldehyde stems from our previous exploration of different azaheteroaromatic curcumin analogs (indoles, quinolines, isoquinolines, pyridines, pyrroles, …) and their biological assessment [14] [15] [16] [17] [18] . The low yield of indole 5 relates to a low conversion and a cumbersome purification via column chromatography to obtain an analytically pure sample. When the reaction time was extended (up to 8 days), mainly degradation was observed. Furthermore, monocarbonyl compounds 2a, 2b were subjected to hydrazine hydrate in acetic acid to effect cyclization en route to the corresponding N-acetylpyrazoline derivatives 3a, 3b (Scheme 1) [22, 23] . The correct molecular structure of the latter azaheterocycles 3 was secured by means of single-crystal X-ray analysis of pyrazoline 3b (Fig. 1 ). The added value of transforming curcumins into pyrazolines relates to the introduction of sp 3 carbons in their structure, conveying three-dimensionality to these scaffolds ('escape from flatland' strategy), as it has been established in the literature that the design of out-of-plane compounds often results in increased solubility, enhanced target selectivity and fewer off-target effects [24, 25] .
Previously, non-symmetrical monocarbonyl analogs have been shown to exhibit good chemical stability in a phosphate buffer medium [26] . Furthermore, the effects of two representative analogs regarding their in vitro anti-inflammatory activity on the apoptosis pathway MAPKs/NF-κB and in in vivo animal models have been studied [9] , demonstrating their biological relevance.
In a first round of screening, the obtained (pyrazoline) monocarbonyl curcumin analogs 2a, 2b, 3a, 3b, and 5 were evaluated for in vitro cytotoxicity on five different cell lines (HepG2, HT-29, Caco-2, EAhy.926 and CHO-K1) by two different endpoint-based cytotoxicity assays. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay relies on the mitochondrial activity of living cells to convert the yellow MTT substrate into purple formazan crystals that can be measured spectrophotometrically. The sulforhodamine B (SRB) assay is based on the stoichiometric binding of the SRB dye to cellular proteins under mild acidic conditions and its subsequent extraction under basic conditions. The amount of dye extracted is related to the cell mass and thus the number of cells in a sample. In both assays, curcumin was included as a reference. The results obtained in this study are reported in Table 1 .
These data demonstrate that the vanillin-derived monocarbonyl curcumin derivative 2a exhibits an improved cytotoxic effect on all cell lines, when compared to curcumin. On the other hand, the p-methoxy analog 2b shows a similar or slightly decreased antiproliferative activity than curcumin. Among the N-acetylpyrazoline congeners 3, the vanillin derivative 3a displayed a similar cytotoxicity profile as curcumin, whereas the non-phenolic p-methoxy analog 3b is a rather weak cytotoxic agent.
These observations point toward the crucial importance of the phenolic hydroxyl group for cytotoxic activity. Finally, the indole-based monocarbonyl curcuminoid 5 is endowed with promising cytotoxicity, except on the liver cancer cell line HepG2.
To complement these endpoint viability assays, the most promising compounds from this initial screening (compounds 2a, 3a, 5, and curcumin as a reference compound) were also evaluated in a real-time IncuCyte proliferation assay against an array of solid and hematological cancers including LN-229 (glioblastoma), Capan-1 (pancreatic adenocarcinoma), Hap-1 (chronic myeloid leukemia), HCT-116 (colorectal carcinoma), NCI-H460 (lung carcinoma), DND-41 (acute lymphoblastic leukemia), HL-60 (acute myeloid leukemia), K-562 (chronic myeloid leukemia) and Z-138 (non-Hodgkin lymphoma) cell lines ( Table 2 ). Whereas curcumin displayed potent cytotoxic activity against a selection of cancer cell lines (Capan-1, Hap-1, HCT-116, Z-138), its cytotoxicity is much less pronounced in other cells (e.g., LN-229, NCI-H460 and K-562). On the other hand, the monocarbonyl curcuminoids 2a, 3a, and 5 are endowed with potent cytotoxic activity against all tumor cell lines tested with IC 50 values in the 1-5 µM range.
To assess the selectivity of these monocarbonyl derivatives (compounds 2a, 3a, and 5) versus normal, non-cancer cells, their toxicity toward peripheral blood mononuclear cells (PBMCs), isolated from two healthy donors, was evaluated, by measuring in real-time the apoptosis induced by the compounds. Addition of the IncuCyte Caspase-3/7 reagent to apoptotic cells, leads to its cleavage by the activated caspase-3/7, resulting in the release of a DNA dye and allowing the green fluorescent staining of nuclear DNA at two different time points (24 and 72 h). Staurosporine, a well-known inducer of apoptosis, was included as a positive control, at a concentration of 1 µM and the fluorescence (and hence, the number of apoptotic cells) measured under these conditions was set at 100%. The IC 50 data as shown in Table 3 are relative to this value. Compounds 2a and 5 are potent apoptogenic agents, displaying IC 50 values in the 1-4 µM range, whereas curcumin itself is not a potent inducer of apoptosis. Compound 3a is a promising compound, because of its excellent antiproliferative activity against a broad range of cancer cell lines, whereas it lacks apoptogenic activity in healthy cells.
Conclusion
Curcumins are promising antitumoral agents, but the metabolic instability of the β-dicarbonyl entity hampers their further development. Therefore, in this manuscript, the potential of monocarbonyl curcuminoids to act as surrogates for curcumins was explored by the synthesis of a small set of representative examples. To that end, 3-methoxy-4-hydroxy-and 4-methoxyphenyl-substituted monocarbonyls 2a, 2b were constructed, as well as the corresponding outof-plane N-acetylpyrazoline derivatives 3a, 3b. In addition, an indole-containing monocarbonyl curcumin analog 5 was synthesized as well. All compounds were initially screened for cytotoxic activity using two different endpoint cell viability assays. The most promising congeners were further tested against a broad panel of cancer cell lines using a real-time assay system. This revealed excellent broad spectrum cytotoxic activity for the 4-hydroxy-pyrazoline-monocarbonyl curcuminoid (compound 3a). Given the fact that this compound lacks apoptogenic activity in normal, healthy cells, it can be considered as a promising lead structure for further elaboration of antitumoral curcumin analogs.
Experimental
All reagents were purchased from commercial suppliers without further purification. 1 H NMR spectra were recorded at 400 MHz (Bruker Avance III Nanobay) with CDCl 3 , DMSO-d 6 , or MeOD-d 4 as solvent. 13 C NMR spectra were recorded at 100.6 MHz (Bruker Avance III Nanobay) with CDCl 3 , DMSO-d 6 , or MeOD-d 4 as solvent. Low resolution mass spectra (LR-MS) were recorded by injection on an Agilent 1100 Series LC/MSD type SL mass spectrometer with electrospray ionization (ESI 70 eV) and using a massselective detector (quadrupole). When crude reaction mixtures were analyzed, the mass spectrometer was preceded by a HPLC reversed-phase column (Ascentis ® Express C18, HPLC column 3 cm × 4.6 mm, 2.7 µm) with a diode array UV-Vis detector. The purity of all tested compounds was assessed by 1 H NMR analysis and/or HPLC analysis, confirming a purity of ≥ 95%.
Synthesis of symmetrical and non-symmetrical monocarbonyl curcuminoids 2, 4, and 5
To a solution of different benzaldehydes (5.6 mmol) in acetone (2.8 mmol), saturated NaOH in methanol was added dropwise, and the mixture was stirred at room temperature for 3-6 h. The resulting solution was then quenched with 10 cm 3 water, while the residual acetone (if any) was removed under reduced pressure followed by extraction with EtOAc. The combined organic layers were washed with 30 cm 3 brine and dried over anhydrous MgSO 4 , filtered, and concentrated under reduced pressure. The residue was further purified by either normal-phase (SiO 2 ) or reversedphase (C18) column chromatography to obtain compounds 2a, 2b.
For the preparation of analog 4, vanillin (5.6 mmol) was used in a similar procedure as for compounds 2, followed by the addition of an excess of acetone (3.0 cm 3 ) to inhibit the formation of compound 2a and to furnish the expected intermediate 4 for further use. Compound 4 (1.5 mmol) was first dissolved in methanol, followed by the addition of indole-3-carboxaldehyde (1.7 mmol) to the solution. Sequentially, saturated NaOH in methanol was added dropwise, and the mixture was stirred at room temperature. After 1 day, the reaction was neutralized and concentrated under reduced 
(E)-4-(4-Hydroxy-3-methoxyphenyl)but-3-en-2-one (4) [21]
Pale-yellow solid; yield: 861 mg (80%); 1 
(1E,4E)-1-(4-Hydroxy-3-methoxyphenyl)-5-(1H-indol-3-yl)penta-1,4-dien-3-one (5, C

Synthesis of pyrazoline analogs 3
A mixture of (1E,4E)-1,5-bisarylpenta-1,4-dien-3-one 2 (2 mmol) and hydrazine hydrate (85%, 10 mmol) in 5 cm 3 glacial acetic acid was heated at reflux temperature for 16-24 h. The reaction progress was monitored by either TLC or LC-MS. After completion of the reaction, the reaction mixture was neutralized by pouring it into an ice-cold NaHCO 3 solution. The resulting solid was suction filtered, washed with water, dried over vacuum, and subjected to column chromatography, as previously described in the literature [22, 23] . 1-[5-(4-Hydroxy-3-methoxyphenyl)-3-(4-hydroxy-3 
(E)-
X-ray crystallography analysis of 3b
For the structure of 3b, X-ray intensity data were collected at 100 K, on a Rigaku Oxford Diffraction Supernova Dual Source (Cu at zero) diffractometer equipped with an Atlas CCD detector using ω scans and CuKα (λ = 1.54184 Å) radiation. The images were interpreted and integrated with the program CrysAlisPro [28] . Using Olex2 [29] , the structure was solved by direct methods using the ShelXS structure solution program and refined by full-matrix least-squares on F 2 using the program package [30, 31] . Non-hydrogen atoms were anisotropically refined and the hydrogen atoms in the riding mode and isotropic temperature factors fixed at 1.2 times U(eq) of the parent atoms (1.5 times for methyl groups). Hydrogen atoms on the water solvent molecule were located from a difference Fourier electron density map and restrained refined (O-H distance of 0.84 Å). 
Mitochondria activity (MTT) experiments
Throughout the experiment, standard procedures were used to maintain all cell lines at 37 °C with 95% humidity and 10% CO 2 . The MTT assay was performed to determine the number of viable cells in this assay. Briefly, 2 × 10 4 cells suspended in 200 mm 3 DMEM medium were first inoculated into each well of 96-well microplates and incubated for 24 h. Then, the medium in each well was removed and an equal volume of serum-free medium (200 mm 3 /well) containing either test compounds or reference control (curcumin) at various concentrations was added for 72 h. Each compound was performed in triplicate. Afterwards, the cell viability was determined by removing 100 mm 3 of medium and adding 20 mm 3 of MTT solution (5 mg/mm 3 in PBS) followed by 2 h of incubation. Finally, the DMEM medium with MTT solution was then removed and replaced with DMSO to dissolve the formazan crystal. The 96-well microplate was then measured at 570 nm using a Spectramax (Molecular Devices) microplate spectrophotometer. For the data analysis, the percentage of surviving cells after a 72 h exposure to various concentrations of each test compound was calculated to obtain the IC 50 value of each compound.
Protein content (SRB) analysis
The SRB assay is based on the measurement of cellular proteins. Sulforhodamine B binds electrostatically with basic amino acid residues if the cells are fixed with trichloroacetic acid (TCA) and can be solubilized by weak bases. Because of this quantitative staining capacity of SRB, the assay is used to screen for cytotoxicity and cell density. The cells were seeded at a concentration of 2 × 10 4 cells per well, incubated for 24 h and treated with or without (control) compounds. Three days after this treatment, the cells were fixed by the addition of 50 mm 3 of 50% TCA in Milli-Q water for 1 h in the cold room, 4 °C. The plate was washed at least three times with tap water and dried, after which the cells were stained with an SRB solution (0.4% sulforhodamine B in 1% glacial acetic acid) at 4 °C. After 30 min, the plate was rinsed for five times with 1% glacial acetic acid and dried. Sequentially, Tris buffer in a concentration of 10 mM was used to re-dissolve the stain. Finally, the absorbance was measured using the microplate spectrophotometer at a wavelength of 490 nm. Each condition was performed in triplicate.
IncuCyte proliferation assay
All tumor cell lines were acquired from the American Type Culture Collection (ATCC, Manassas, VA, USA), except for the DND-41 cell line, which was purchased from the Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ Leibniz-Institut, Germany), and the Hap-1 cell line which was ordered from Horizon Discovery (Horizon Discovery Group, UK). All cell lines were cultured as recommended by the suppliers. Media were purchased from Gibco Life Technologies, USA, and supplemented with 10% fetal bovine serum (HyClone, GE Healthcare Life Sciences, USA). Adherent cell lines HCT-116, NCI-H460, LN-229, Hap-1 and Capan-1 cells were seeded at a density between 500 and 1500 cells per well, in 384-well, black-walled, clear-bottomed tissue culture plates (Greiner). After overnight incubation, cells were treated with the test compounds at seven different concentrations ranging from 100 to 6.4 × 10 −3 µM. Suspension cell lines HL-60, K-562, Z-138, and DND-41 were seeded at densities ranging from 2500 to 5500 cells per well in 384-well, black-walled, clearbottomed tissue culture plates containing the test compounds at the same seven concentration points. The plates were incubated and monitored at 37 °C for 72 h in an IncuCyte ® (Essen BioScience Inc., Ann Arbor, MI, USA) for real-time imaging. Images were taken every 3 h, with one field imaged per well under 10× magnification.
PBMCs were seeded at 28,000 cells per well in 384-well, black-walled, clear-bottomed tissue culture plates containing the test compounds at seven different concentrations ranging from 100 to 6.4 × 10 −3 µM. IncuCyte ® Caspase 3/7 Green Reagent was added as recommended by the supplier, and the plates were incubated and monitored at 37 °C for 3 days in an IncuCyte ® (Essen BioScience Inc., Ann Arbor, MI, USA) for real-time imaging. Images were taken every 3 h, with one field imaged per well under 10× magnification.
